Jonathan Oberlander, PhD, is co-editor of a new special issue on “The Price of Progress: Managing Prescription Drug Spending” published by the Journal of Health Politics, Policy, and Law. The issue considers the sources of high drug spending in the U.S. and policy reforms to make prescription drugs more affordable, including analysis of provisions of the recently enacted Inflation Reduction Act.